PL EN


Preferences help
enabled [disable] Abstract
Number of results
Journal
2014 | 1 | 4 | 233-238
Article title

Terapia łączona w leczeniu obrzęku plamki w przebiegu niedrożności naczyń żylnych siatkówki

Content
Title variants
EN
Combined therapy in treatment of macular oedema in retinal vein occlusion
Languages of publication
PL
Abstracts
PL
Zakrzep żyły siatkówki oraz wynikające z niego powikłania obok cukrzycowego obrzęku plamki stanowią najczęstsze naczyniowe zaburzenia w obrębie siatkówki, które mogą prowadzić do znacznej, często nieodwracalnej utraty widzenia. Leczenie powikłań zakrzepu żyły siatkówki, zarówno żyły głównej, jak i jej gałęzi, stanowi w dalszym ciągu wyzwanie, pomimo dostępności różnych alternatywnych metod. Celem pracy jest przedstawienie przypadków klinicznych pacjentów, u których uzyskano korzystne efekty czynnościowe i anatomiczne po zastosowaniu terapii łączonej: doszklistkowych iniekcji ranibizumabu oraz laseroterapii laserem żółtym o długości fali 577 nm (Integre Yellow Ellex).
EN
Retinal vein occlusion and the complications which arise from it, next to diabetic macular oedema, is the most common vascular disease in retina, witch can lead to significant visual loss. Treatment of retinal vein occlusion complications, both central retinal vein occlusion and branch retinal vein occlusion are still difficult, though many alternative forms of treatment exist. The aim of the study is to present two clinical cases after combined therapy: intravitreal ranibizumab and laser therapy by yellow laser of 577 nm wave lenght (Integre Yellow Ellex).
Discipline
Publisher
Journal
Year
Volume
1
Issue
4
Pages
233-238
Physical description
Contributors
  • Oddział Okulistyczny, Szpital Wojewódzki w Łomży
author
  • Oddział Okulistyczny, Szpital Wojewódzki w Łomży
  • Oddział Okulistyczny, Szpital Wojewódzki w Łomży
References
  • 1. Hayreh S. Prevalent misconceptions about acute retinal vascular occlusive disorders. Prog Retin Eye Res 2005; 24: 493-519.
  • 2. Mitchell P, Smith W, Chang A. Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountains Eye Study. Arch Ophthalmol 1996; 114: 1243-1247.
  • 3. Hayreh S, Zimmerman M, Podhajsky P. Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics. Am J Ophthalmol 1994; 117: 429-441.
  • 4. Rogers S, McIntosh RL, Cheung N, et al. The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia. Ophthalmology 2010; 117: 313-319.
  • 5. McIntosh RL, Rogers SL, Lim L, et al. Natural history of central retinal vein occlusion: an evidence-based systematic review. Ophthalmology 2010; 117: 1113-1123.
  • 6. The Central Vein Occlusion Study Group. Natural history and clinical management of central retinal vein occlusion. Arch Ophthalmol 1997; 115: 486-491.
  • 7. Brown DM, Campochiaro PA, Singh RP, et al. Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology 2010; 117: 1124-1133.
  • 8. Todorich B, Lin P, Shieh C, et al. Efficacy of aflibercept for the treatment of chronic non-ischemic CRVO-associated macular edema after treatment with other anti-VEGF agents. J Eye Ophthalmol 2014; 1: 3.
  • 9. Jung SH, Kim K, Sohn SW, et al. Association of aqueous humor cytokines with the development of retinal ischemia and recurrent macular edema in retinal vein occlusion. Invest Ophthalmol VIS SCI 2014; 4: 2290-2296.
  • 10. Haller JA, Bandello F, Belfort R Jr, et al. OZURDEX GENEVA Study Group. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology 2010; 117(6): 1134-1146.
  • 11. The SCORE Study Research Group. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs. Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5. Arch Ophthalmol 2009; 127: 1101-1104.
  • 12. The Central Vein Occlusion Study Group M report. Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion. Ophthalmology 1995; 102: 1425-1433.
  • 13. The Branch Vein Occlusion Study Group. Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol 1984; 98(3): 271-282.
  • 14. Luttrull JK, Dorin G. Subthreshold Diode Micropulse Laser Photocoagulation (SDM) as Invisible Retinal Phototherapy for Diabetic Macular Edema: A Review Curr Diabetes Rev 2012; 8(4): 274-284.
  • 15. Noma H, Mimura T, Shimada K. Changes of macular sensitivity and morphology after pars plana vitrectomy for macular edema with central retinal vein occlusion: a case series. BMC Ophthalmology 2013; 13: 2.
  • 16. DeCroos FC, Shuler RK Jr, Stinnett S, et al. Pars plana vitrectomy, internal limiting membrane peeling, and panretinal endophotocoagulation for macular edema secondary to central retinal vein occlusion. Am J Ophthalmol 2009; 147(4): 627-633.
Document Type
article
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.psjd-64dada2b-2d56-4bd6-ac3e-7dd4a640cc5d
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.